Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalfurafine Bridging Study for Uremic Pruritus in China
NCT04728984Phase 3Unknown
- Sponsor
- 3SBio
- Start
- Sep 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nalfurafine in uremic pruritus, sponsored by 3SBio. Status: unknown.
02
Drugs
nalfurafine
03
Conditions
uremic pruritus
Beyond the preview
Go deeper on NCT04728984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04728984.